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The repercussions of drug abuse are particularly empha-
sized when a pregnant woman is affected. Gestational
drugexposure is associated with significantly increased risks
of poor maternal health, adverse perinatal outcomes, and
unfavourable psychosocial consequences. Children affected
by maternal drug use are at particular risk form their parent’s
drug seeking behavior as well as the toxicological effects of
the drugs used. Early identification is key, and considerably
more research is needed to develop the optimum means
by which affected mother-infant dyads may be recognized
and supported. In this special issue, we present six papers
that deal with the problems caused by gestational drugs of
dependency.
“Pregnant and non-pregnant women in cape town, South
Africa: drug use, sexual behavior, and the need for comprehen-
sive services” deals with the problem of methamphetamine
use in pregnant women in South Africa, a country where
poverty and HIV risk are high. The authors find that
methamphetamine, a drug highly associated with adverse
psychosocial sequelae, is proportionally used by more preg-
nant than non-pregnant women, a practice that could have
far-reaching effects on their families.
“Drug testing for newborn exposure to illicit substances in
pregnancy: pitfalls and pearls” in this special issue provides
an overview of drug testing of newborns. Accurate recog-
nition of a newborn whose mother has used illicit drugs
during pregnancy influences decisions regarding healthcare
of mother and infant whilst in hospital and following
discharge. The difference between screening and confirma-
tory drug testing and the potential for false-positive results by
immunoassay screening are discussed. Testing of newborns
for illicit drugs can be done on urine, blood, meconium, hair,
and umbilical cord blood or tissue samples. The implications
and limitations of drug testing are presented. The authors
caution that illicit drug use in pregnancy is not an indepen-
dent predictor of a mother’s ability to adequately care for her
child but needs to be considered in health care planning.
“Initial feasibility of a woman-focused intervention for
pregnant African-American women” reports on the diffi-
culties faced by drug-using women in accessing antenatal
care and contraception compared to the general pregnant
population. The authors discuss challenges faced in the
development of innovative and effective systems to educate
affected women and to provide adequate care for the women
and their children.
“Pharmacological treatment of neonatal opiate with-
drawal: between the devil and the deep blue sea” deals with the
issues faced by clinicians on how to optimize treatment of the
newborn infant withdrawing from maternal opiates. They
emphasize that current clinical research and evidence on the
long term development of children affected by in utero opiate
exposure is limited as are the effects of pharmacological
treatment on these infants, especially when there is an
increasing body of evidence suggesting that opiates may
not have a benign influence on fetal or, indeed, neonatal
neurodevelopment.
“Psychosocial characteristics and obstetric health of women
attending a specialist substance use antenatal clinic in
a large metropolitan hospital” investigates the outcomes
of a community-based intervention to improve drug-use
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behavior and social circumstances of crack-using African-
American women. It highlights, in particular, the benefits
of training in social skills such as relationship support to
alleviate lifestyle issues associated with highly dependent
drug-use behaviors.
“Effectiveness of a smoking cessation intervention for
methadone-maintained women: a comparison of pregnant and
parenting women” examines the effects of an intervention
aimed to reduce cigarette smoking for women in substance
abuse programs. This is particularly important as cigarette
smoking compounds the risk of adverse perinatal and neona-
tal outcomes in this population, and the paper highlights
the benefits of addressing what would often be considered
a trivial problem for the drug-using woman.
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